Research Nester published a report titled “Defibrillators Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global defibrillators market in terms of market segmentation by product type, end user, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global defibrillators market is anticipated to grow with a CAGR of ~7% during the forecast period, i.e., 2023-2035. The market is segmented by end users into hospitals, medical centers, homecare, and others. Out of these, the hospitals segment is anticipated to garner the largest revenue by the end of 2031. As a result of both the high number of cardiac patients being treated along with the increase in the number of heart surgeries that are being performed in hospitals, there is a significant growth in the segment. For instance, there are over 480,000 heart surgeries performed every year in the United States.
The global defibrillators market is estimated to garner revenue of USD 20 Billion by the end of 2031, up from revenue of USD 11 Billion in the year 2021. Rising incidences of SCA and CVDs along with the increasing healthcare expenditure are expected to drive the global defibrillators market during the forecast period. Moreover, rise in older population, increasing training courses on the usage of Automated External Defibrillator (AEDs) are some of the major factors anticipated to drive the growth of the market during the forecast period.
Geographically, the global defibrillators market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Out of these, the market in North America is projected to garner the largest revenue by the end of 2031.Increasing cardiovascular disease incidence in the United States is expected to drive the regional market. Over 795,000 people had heart attacks and nearly 697,000 died of heart disease in 2020, according to the Centers for Disease Control and Prevention.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Increased incidence of lifestyle diseases like hypertension and diabetes to Drive the Market Growth
Based on the findings, it has been observed that the prevalence of diabetes is estimated to be 9.2% (460 million people) in 2019, and it is expected to go up to 10% (570 million) by 2030.
Hypertension, obesity, dyslipidemia, and diabetes are all lifestyle diseases that have grown tremendously in the last few decades, which are leading causes of cardiovascular diseases around the globe. The development of cardiovascular diseases is strongly correlated with a high level of blood pressure. As a result, there is a growing case of lifestyle diseases that are expected to contribute to the growth of the global defibrillator market during the forecasting period.
However, the presence of non-branded, low cost defibrillators in the market are expected to operate as key restraint to the growth of global defibrillators market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global defibrillators market which includes company profiling of Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, ZOLL Medical Corporation, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and Abbott. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global defibrillators market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Request Report Sample@ https://www.researchnester.com/sample-request-4284
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: [email protected]
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919